Edico Genome specializes in next-generation sequencing (NGS) technologies that enable rapid and high-quality genomic analysis. Their product offerings include advanced sequencing platforms such as the MiSeq i100 Series and the NextSeq 1000 and 2000 systems, which utilize innovative XLEAP-SBS chemistry to enhance sequencing speed and accuracy. The company also provides a range of kits and reagents for library preparation and sequencing, catering to various applications in clinical research, oncology, and agrigenomics. Their tools, such as the NGS Workflow Finder and DesignStudio Custom Assay Designer, assist researchers in optimizing their sequencing workflows and designing custom assays tailored to specific research needs.

In addition to their sequencing instruments, Edico Genome offers comprehensive software and analysis services, including the BaseSpace Sequence Hub and DRAGEN Secondary Analysis, which facilitate efficient data processing and interpretation. Their focus on multiomics and high-throughput sequencing allows for deeper studies across diverse fields, including cancer research and microbiology. The company also emphasizes proactive instrument monitoring and training services to ensure optimal performance and minimize downtime, thereby supporting laboratories in achieving their genomic research goals with confidence and efficiency.

United States

Edico Genome is a biotechnology company that specializes in developing cutting edge solutions for genomic sequencing analysis to provide unprecedented speed, scale, and accuracy.

Edico Genome

Company Details